IL17A and malignant colon neoplasm: Indeed, Lotti et al. have reported that IL-17A secretion is increased in fibroblasts isolated from colon cancer patients undergoing cytotoxic drug treatment regimens and subsequently causes chemotherapeutic resistance in colon cancer [22].